ClinicalTrials.gov
ClinicalTrials.gov Menu

Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday (CONTINUITY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01854086
Recruitment Status : Unknown
Verified May 2013 by Meir Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : May 15, 2013
Last Update Posted : May 15, 2013
Sponsor:
Information provided by (Responsible Party):
Meir Medical Center

Brief Summary:
The purpose of the study is to provide information about the rate of response and persistence to drug therapies for osteoporosis. Another issue examined in this study refers to the preferences and concerns about future treatments in patients during "drug holiday".

Condition or disease Intervention/treatment
Osteoporosis Other: Questionnaires about compliance and persistence with bisphosphonates treatment

Study Type : Observational [Patient Registry]
Estimated Enrollment : 150 participants
Observational Model: Case-Only
Time Perspective: Prospective
Target Follow-Up Duration: 1 Day
Official Title: Compliance and Persistence With Osteoporosis Treatment and Attitude Towards Future Therapy Among Post-menopausal Israeli Women During Drug Treatment or Drug Holiday: Data From a Single Outpatient Endocrine Clinic.
Study Start Date : September 2013
Estimated Primary Completion Date : February 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Osteoporosis

Group/Cohort Intervention/treatment
Postmenopausal women
Postmenopausal women treated with bisphosphonates
Other: Questionnaires about compliance and persistence with bisphosphonates treatment



Primary Outcome Measures :
  1. Compliance and persistence to osteoporosis drug therapy [ Time Frame: Participants will be followed for the duration of their clinic visit, an average of 5 hours ]
    Data collection will be done by questionnaires and from the medical record of the patient. The information collected will include: demographic information, measurements of bone density, additional information about the disease and treatment that the patient receives,prescription purchases and additional drugs the patient is taking (steroids, PPI's(Proton Pump Inhibitors) / H2 receptor antagonists and NSAIDs(Non Steroidal Anti Inflammatories)).



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   40 Years to 90 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with osteoporosis,who been treated in Endocrinology Clinic of Medical Center
Criteria

Inclusion Criteria:

  • Postmenopausal women
  • Diagnosis of osteoporosis in the medical record
  • At least one prescription drug to treat osteoporosis in the last 5 years
  • Insured by "Clalit" Health Services
  • Hebrew-speaking capability and readiness to answer a questionnaire

Exclusion Criteria:

  • Premenopausal women
  • No diagnosis of osteoporosis in the medical record
  • No treatment for osteoporosis in the last 5 years
  • Women who do not speak Hebrew or are unable to answer a questionnaire

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01854086


Contacts
Contact: Pnina Rotman, M.D 972-57-7482609 Pnina.Rotman@clalit.org.il

Locations
Israel
Meir medical center the clalit health care services group Not yet recruiting
Kfar Saba, Israel, 44281
Contact: Pnina Rotman, M.D    972-57-7482609    Pnina.Rotman@clalit.org.il   
Principal Investigator: Pnina Rotman, M.D         
Sponsors and Collaborators
Meir Medical Center

Publications of Results:
Responsible Party: Meir Medical Center
ClinicalTrials.gov Identifier: NCT01854086     History of Changes
Other Study ID Numbers: MMC130009-13CTIL
First Posted: May 15, 2013    Key Record Dates
Last Update Posted: May 15, 2013
Last Verified: May 2013

Keywords provided by Meir Medical Center:
osteoporosis
postmenopausal
patient compliance
compliance
diphosphonates
bisphosphonates

Additional relevant MeSH terms:
Osteoporosis
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases
Metabolic Diseases
Diphosphonates
Bone Density Conservation Agents
Physiological Effects of Drugs